Christian Gays The FELGTB joins the rest of Europe to participate in the first European Week HIV Test.
FELGTB joins organizations, institutions, key opinion makers and government leaders from across making almond butter Europe in the week to raise awareness of the benefits of HIV testing. The European Week HIV Test was coordinated by HIV in Europe * and aims to reduce late diagnosis, in order to ensure that more and more people making almond butter become aware of their current HIV status. The campaign "Speak of HIV. Take the Test "has been promoted as supporting dialogue, to encourage people and most vulnerable populations to seek an HIV test, and ensure that the coverage of HIV testing increases.
The unacceptable reality is that about 30% of the estimated 130,000-150,000 people living making almond butter with HIV in Spain know they are infected by the virus. When people are diagnosed late access to health care is delayed, so are more likely to develop health making almond butter complications.
It is shown that most people with HIV who know they are infected take appropriate measures to avoid transmitting the virus to their sexual partners. Besides the initiation and maintenance of antiretroviral therapy making almond butter is able to reduce the viral load and thus the likelihood of transmitting the virus, as an added benefit to improving survival and quality of life provided by these treatments for those infected.
Santiago Redondo, coordinator of Health making almond butter explains FELGTB "access to antiretroviral treatment has been a definite improvement in reducing morbidity and mortality making almond butter in people with HIV for almost twenty years now, making infection HIV into a chronic disease evolution. HIV testing is, today, making almond butter the only way to know the HIV status making almond butter and benefit of treatments and health care. "
Research has shown that most people would accept a test for HIV if you are encouraged to do so. Therefore, in addition making almond butter to encouraging people to apply for a test, the Test Week aims to encourage health professionals and those responsible for testing programs to provide HIV testing when appropriate and necessary.
Boti G Rodrigo, President of FELGTB said: "Our federation has a strong commitment to HIV prevention and support for those affected, and one of the ways it manifests is the development of facilities for rapid test between our member institutions . According to the EMIS report, funded by the European Commission, 18% of HIV tests that are MSM in Spain, in centers like ours. "
Santiago Redondo, added: "Early diagnosis is a key element to prevent new infections, but there are other challenges in responding to HIV deserve the same dedication and resources to ensure universal access to health care or reducing stigma and discrimination associated with HIV "
HIV in Europe is a pan-European initiative launched in Brussels in 2007. The initiative serves as a European platform for exchange and activities to improve early diagnosis and treatment of HIV in Europe. The initiative is run by an independent group of experts, civil society representatives, politicians, making almond butter health professionals and European making almond butter public health institutions.
HIV in Europe is not an organization, but an initiative to concrete actions, share knowledge and improve information on highlights of the tests and early treatment. It is unique in its collaboration among stakeholders to clinical, legal and public health level. making almond butter
HIV in Europe receives financial support: Gilead Sciences, Merck, making almond butter Tibotec, Pfizer, Schering-Plough, Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, ViiV Healthcare, the European Commission under the Health Programme 2008-2013 and the Council Swedish making almond butter Research.
Reminder The images and photographs presented in this blog are the property making almond butter of their respective authors or copyright holders and are reproduced solely for informational, illustrative and non-profit purposes. I, of course, at the request of the authors, will eliminate the content in question immediately or add a link. This site is free and does not generate revenue. The owner of the blog does not guarantee the robustness and reliability of its content. This blog is a place of entertainment. The information may contain errors and inaccuracies. This blog has no control over the content of sites to which a link is provided. His owner can not be held liable.
To join this group is
FELGTB joins organizations, institutions, key opinion makers and government leaders from across making almond butter Europe in the week to raise awareness of the benefits of HIV testing. The European Week HIV Test was coordinated by HIV in Europe * and aims to reduce late diagnosis, in order to ensure that more and more people making almond butter become aware of their current HIV status. The campaign "Speak of HIV. Take the Test "has been promoted as supporting dialogue, to encourage people and most vulnerable populations to seek an HIV test, and ensure that the coverage of HIV testing increases.
The unacceptable reality is that about 30% of the estimated 130,000-150,000 people living making almond butter with HIV in Spain know they are infected by the virus. When people are diagnosed late access to health care is delayed, so are more likely to develop health making almond butter complications.
It is shown that most people with HIV who know they are infected take appropriate measures to avoid transmitting the virus to their sexual partners. Besides the initiation and maintenance of antiretroviral therapy making almond butter is able to reduce the viral load and thus the likelihood of transmitting the virus, as an added benefit to improving survival and quality of life provided by these treatments for those infected.
Santiago Redondo, coordinator of Health making almond butter explains FELGTB "access to antiretroviral treatment has been a definite improvement in reducing morbidity and mortality making almond butter in people with HIV for almost twenty years now, making infection HIV into a chronic disease evolution. HIV testing is, today, making almond butter the only way to know the HIV status making almond butter and benefit of treatments and health care. "
Research has shown that most people would accept a test for HIV if you are encouraged to do so. Therefore, in addition making almond butter to encouraging people to apply for a test, the Test Week aims to encourage health professionals and those responsible for testing programs to provide HIV testing when appropriate and necessary.
Boti G Rodrigo, President of FELGTB said: "Our federation has a strong commitment to HIV prevention and support for those affected, and one of the ways it manifests is the development of facilities for rapid test between our member institutions . According to the EMIS report, funded by the European Commission, 18% of HIV tests that are MSM in Spain, in centers like ours. "
Santiago Redondo, added: "Early diagnosis is a key element to prevent new infections, but there are other challenges in responding to HIV deserve the same dedication and resources to ensure universal access to health care or reducing stigma and discrimination associated with HIV "
HIV in Europe is a pan-European initiative launched in Brussels in 2007. The initiative serves as a European platform for exchange and activities to improve early diagnosis and treatment of HIV in Europe. The initiative is run by an independent group of experts, civil society representatives, politicians, making almond butter health professionals and European making almond butter public health institutions.
HIV in Europe is not an organization, but an initiative to concrete actions, share knowledge and improve information on highlights of the tests and early treatment. It is unique in its collaboration among stakeholders to clinical, legal and public health level. making almond butter
HIV in Europe receives financial support: Gilead Sciences, Merck, making almond butter Tibotec, Pfizer, Schering-Plough, Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, ViiV Healthcare, the European Commission under the Health Programme 2008-2013 and the Council Swedish making almond butter Research.
Reminder The images and photographs presented in this blog are the property making almond butter of their respective authors or copyright holders and are reproduced solely for informational, illustrative and non-profit purposes. I, of course, at the request of the authors, will eliminate the content in question immediately or add a link. This site is free and does not generate revenue. The owner of the blog does not guarantee the robustness and reliability of its content. This blog is a place of entertainment. The information may contain errors and inaccuracies. This blog has no control over the content of sites to which a link is provided. His owner can not be held liable.
To join this group is
No comments:
Post a Comment